- Home
- ASTC vs IMRN Comparison
ASTC vs IMRN Comparison
Compare ASTC & IMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASTC
- IMRN
- Stock Information
- Founded
- ASTC 1984
- IMRN 1994
- Country
- ASTC United States
- IMRN Australia
- Employees
- ASTC N/A
- IMRN N/A
- Industry
- ASTC Biotechnology: Laboratory Analytical Instruments
- IMRN Biotechnology: Pharmaceutical Preparations
- Sector
- ASTC Industrials
- IMRN Health Care
- Exchange
- ASTC Nasdaq
- IMRN Nasdaq
- Market Cap
- ASTC 8.6M
- IMRN 9.2M
- IPO Year
- ASTC 1995
- IMRN N/A
- Fundamental
- Price
- ASTC $5.00
- IMRN $1.86
- Analyst Decision
- ASTC
- IMRN Strong Buy
- Analyst Count
- ASTC 0
- IMRN 1
- Target Price
- ASTC N/A
- IMRN $5.00
- AVG Volume (30 Days)
- ASTC 4.8K
- IMRN 55.1K
- Earning Date
- ASTC 05-13-2025
- IMRN 08-29-2025
- Dividend Yield
- ASTC N/A
- IMRN N/A
- EPS Growth
- ASTC N/A
- IMRN N/A
- EPS
- ASTC N/A
- IMRN N/A
- Revenue
- ASTC $903,000.00
- IMRN $4,777,422.00
- Revenue This Year
- ASTC N/A
- IMRN N/A
- Revenue Next Year
- ASTC N/A
- IMRN N/A
- P/E Ratio
- ASTC N/A
- IMRN N/A
- Revenue Growth
- ASTC N/A
- IMRN 48.63
- 52 Week Low
- ASTC $4.71
- IMRN $1.50
- 52 Week High
- ASTC $10.83
- IMRN $2.87
- Technical
- Relative Strength Index (RSI)
- ASTC 44.52
- IMRN 56.87
- Support Level
- ASTC $4.94
- IMRN $1.73
- Resistance Level
- ASTC $5.38
- IMRN $1.89
- Average True Range (ATR)
- ASTC 0.22
- IMRN 0.10
- MACD
- ASTC 0.02
- IMRN 0.01
- Stochastic Oscillator
- ASTC 38.16
- IMRN 76.77
About ASTC Astrotech Corporation (DE)
Astrotech Corp is a science and technology development company. The firm invents, acquires, and commercializes technological innovations sourced from internal research, universities, laboratories, and research institutions. The 1st Detect develops, manufactures, and sells chemical analyzers for use in the airport security, military, and breath analysis markets. AgLAB develops a series of mass spectrometers for use in the agriculture market.
About IMRN Immuron Limited
Immuron Ltd is a commercial and clinical-stage biopharmaceutical company focused on the development and commercialization of a novel class of immunomodulator polyclonal antibodies to treat liver diseases, infectious diseases and other immune-mediated diseases, such as colitis. The company's product, IMM-124E, is a proprietary immunomodulatory agent targeted at GI immune-mediated diseases including fatty liver diseases. The company functions in two segments namely, Research and Development and Hyperimmune products.